NCT00637026View on ClinicalTrials.gov

Ph II Early BC Pre-Surgical Biologic Study

PHASE2CompletedINTERVENTIONAL

Enrollment

65

Participants

Timeline

Start Date

July 31, 2003

Study Completion Date

February 28, 2005

Conditions

Breast Cancer

Interventions

DRUG

Gefitinib

Iressa

Sponsors

Lead Sponsor

All Listed Sponsors

collaborator

Cancer International Research Group (CIRG)

OTHER

lead

AstraZeneca

INDUSTRY